Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on: December 22,2023

Artificial intelligence tracks down leukemia

byGerman Center for Neurodegenerative DiseasesCredit: CC0 Public DomainArtificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reli

Updated on:December 22,2023

When combined, a novel LSD1 inhibitor and an existing therapy enhance each other's anti-cancer effects

by Jaclyn Dunne,Medical University of South CarolinaGraphical abstract. Credit:European Journal of Medicinal Chemistry(2022). DOI: 10.1016/j.ejmech.2022.114818A Medical University of

Updated on: December 20,2023

When combined, a novel LSD1 inhibitor and an existing therapy enhance each other's anti-cancer effects

by Jaclyn Dunne,Medical University of South CarolinaGraphical abstract. Credit:European Journal of Medicinal Chemistry(2022). DOI: 10.1016/j.ejmech.2022.114818A Medical University of

Updated on:December 20,2023

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on: December 18,2023

Consumer health: What is lung cancer screening, and who needs it?

by Laurel KellyCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer deaths in the U.S., according to the American Cancer Society. Lung cancer claims more lives each year than co

Updated on:December 18,2023

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on: December 22,2023

Scientists identify potential drug target for BRCA-mutated tumours

byInstitute of Cancer ResearchCrystal structure of EXD2 exonuclease domain in spacefill format. Credit: Image generated fromPDBA new study has uncovered a previously unknown role for the e

Updated on:December 22,2023

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on: December 22,2023

Pathogenesis to management of hepatocellular carcinoma

by Impact JournalsMolecular pathways and targeted therapeutics in hepatocellular carcinoma. Abbreviations: APC: antigen presenting cell; AXL is a cell surface receptor tyrosine kinase, part of the TAM

Updated on:December 22,2023

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli

Updated on: April 28,2024

Study finds less invasive, safer option for removing benign pancreatic tumors

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainInsulinomas are abnormal tumors, usually benign, that grow in the beta cells of the pancreas. Insulinomas make extra insuli

Updated on:April 28,2024

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel

Updated on: December 27,2023

Gene mutations should be tested routinely for ovarian cancer, say scientists

by Mike Addelman,University of ManchesterCredit: Unsplash/CC0 Public DomainScientists from The University of Manchester have shown that testing for two gene families linked to a lifetime epithel

Updated on:December 27,2023

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m

Updated on: February 18,2024

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m

Updated on:February 18,2024

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on: December 22,2023

Novel combination therapy has similar response rates to chemotherapy for high-risk luminal B breast cancer

byAmerican Association for Cancer ResearchNeoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to m

Updated on:December 22,2023

Low-fat diet could be key to stopping cancer growth

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous

Updated on: December 20,2023

Low-fat diet could be key to stopping cancer growth

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Dan Gold on UnsplashNew research has found food could play a major role in stopping the growth of some cancers.It was previous

Updated on:December 20,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on: December 20,2023

Germany's BioNTech plans UK trial of mRNA cancer therapy

Scientists believe mRNA vaccines could be a game-changer against many diseases.German pharmaceutical company BioNTech, which developed a trailblazing COVID-19 vaccine, will trial a cancer treatment in

Updated on:December 20,2023